Concepedia

N. Bekele

NB

Statistics

Publications

11

Citations

1.2K

H-Index

11

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

N. Bekele is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and molecular oncology.

Publications per year

2003–2012

11

Publications

11

Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

Elias Jabbour, Hagop M. Kantarjian, Dan Jones et al. · Leukemia · 2006 · 387 citations

, , +11

A Phase 2 Trial of Sunitinib in Patients with Advanced Non–clear Cell Renal Cell Carcinoma

Nizar M. Tannir, Elizabeth R. Plimack, Chaan S. Ng et al. · European Urology · 2012 · 165 citations

, , +11

Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Guillermo Garcia‐Manero, Francesco Paolo Tambaro, N. Bekele et al. · Journal of Clinical Oncology · 2012 · 164 citations · Full text

, , +15

Increased phospho-AKT (Ser(473)) expression in bronchial dysplasia: implications for lung cancer prevention studies.

Anne S. Tsao, Timothy J. McDonnell, Stephen Lam et al. · PubMed · 2003 · 128 citations

, , +17

Delta-24-RGD in Combination With RAD001 Induces Enhanced Anti-glioma Effect via Autophagic Cell Death

Marta M. Alonso, Hong Jiang, Tomohisa Yokoyama et al. · Molecular Therapy · 2008 · 115 citations · Full text

, , +17

1–5 of 11